Showing results (231-240 of 244) with videos related to
Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trialJ D Hainsworth, H A Burris, D A Yardley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcomeA F List, J P Greer, J C Cousar, et al.Archives of Internal Medicine|May 1, 1987
Maintenance etidronate in the prevention of malignancy-associated hypercalcemiaJ H Schiller, P Rasmussen, A B Benson, et al.American Journal of Clinical Oncology|April 13, 1999
Adjuvant dose-intense chemotherapy with peripheral blood stem cell support in stage II-III breast cancer with five to nine involved axillary lymph nodesL S Schwartzberg, R Birch, K W Tauer, et al.Cancer|October 12, 2001
Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy for resected nonsmall cell lung carcinoma: a feasibility study of the Minnie Pearl Cancer Research NetworkF A Greco, H A Burris, J R Gray, et al.Cancer|April 3, 1999
Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinomaJ D Hainsworth, H A Burris, J B Erland, et al.Transfusion|October 6, 1997
Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor: an analysis of 497 patientsC H Weaver, L S Schwartzberg, R Birch, et al.Bone Marrow Transplantation|January 7, 1998
High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin's lymphoma: results of outpatient treatment in community cancer centersC H Weaver, L Schwartzberg, B Zhen, et al.Bone Marrow Transplantation|April 1, 1997
Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: outcomes by intent to treat analysesC H Weaver, W H West, L S Schwartzberg, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 1997
Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancerC H Weaver, L S Schwartzberg, R Birch, et al.Pageof 25